Clinical trial

Intra-coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells…

NCT00313339 · Emory University, Other · Completed

Key facts

NCT number NCT00313339
Title Intra-coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction
Official title AMORCYTE MYOCARDIAL REPAIR STUDY- A Phase I Trial of Intra-coronary Infusion of Bone Marrow Derived Autologous CD34+ Selected Cells in Patients With Acute Myocardial Infarction. (AMRS)
Acronym AMR-1
Lead sponsor Emory University, Other
Collaborators Texas Heart Institute
Status Completed
Phase Phase 1
Study type Interventional
Conditions Myocardial Infarction, Coronary Artery Disease
Intervention type Drug
Interventions Intra-coronary infusion
Enrollment 31
Start date Mar 1, 2006
Primary completion Mar 1, 2009
Completion Mar 1, 2013
First posted Apr 12, 2006
Last update posted Nov 18, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies